サマリー

ヘパリンの世界市場 2023-2027
Technavio社は、ヘパリン市場をモニターしており、2023年から2027年にかけて3億944万ドルの成長が見込まれ、予測期間中のCAGRは6.94%で加速すると予測しています。当レポートでは、ヘパリン市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
当レポートでは、現在の世界市場のシナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、凝固障害の有病率の増加、慢性疾患の有病率の増加、ヘパリン製造のための代替ソースの再導入によって牽引されています。
Technavioのヘパリン市場は以下のようにセグメント化されています：
製品別
- 低分子ヘパリン
- その他
投与経路別
- 皮下注射
- 静脈内/点滴
地域別
- 欧州
- 北米
- アジア
- その他の地域 (ROW)
本調査では、今後数年間のヘパリン市場の成長を促進する主な理由の一つとして、ヘパリンの研究開発活動の増加と新たな治療用途を挙げています。また、バイオシミラー低分子ヘパリンの出現と手術後のヘパリン除去薬の開発は、市場の大きな需要につながるでしょう。
Technavioは、主要パラメータの分析による複数の情報源からのデータの調査、合成、要約によって、市場の詳細な姿を提示します。ヘパリン市場に関する弊社のレポートは以下の分野をカバーしています：
- ヘパリン市場のサイジング
- ヘパリン市場の予測
- ヘパリン市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Aspen Pharmacare Holdings, B. Braun SE, Baxter International Inc.Ltd.、Fresenius SE and Co.KGaA、Hebei Changshan Biochemical、Hikma Pharmaceuticals Plc、Laboratorios Farmaceuticos Rovi、LEO Pharma AS、Nanjing Kingfriend Biochemical、Nichi Iko Pharmaceutical Co.Ltd.、ノバルティスAG、オポクリンSpA、ファイザーInc.、サノフィSA、上海佛山薬業集団有限公司、深圳市科大薬業有限公司、上海佛山医薬集団有限公司、深圳市科大薬業有限公司Ltd.、Shenzhen Techdow Pharmaceutical、Teva Pharmaceutical Industries Ltd.、Viatris Inc.また、ヘパリン市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/heparin-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数の情報源からのデータを調査、合成、要約することにより、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global heparin market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global heparin market 2018 - 2022 ($ billion)
o 4.2 Product Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
o 4.3 Route Of Administration Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Route Of Administration Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Low-molecular-weight heparin - Market size and forecast 2023-2028
o Exhibit 34: Chart on Low-molecular-weight heparin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Low-molecular-weight heparin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Low-molecular-weight heparin - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Low-molecular-weight heparin - Year-over-year growth 2023-2028 (%)
o 6.4 Others - Market size and forecast 2023-2028
o Exhibit 38: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ billion)
o Exhibit 43: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 46: Chart on Comparison by Route of Administration
o Exhibit 47: Data Table on Comparison by Route of Administration
o 7.3 Subcutaneous injection - Market size and forecast 2023-2028
o Exhibit 48: Chart on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Subcutaneous injection - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Subcutaneous injection - Year-over-year growth 2023-2028 (%)
o 7.4 Intravenous infusion - Market size and forecast 2023-2028
o Exhibit 52: Chart on Intravenous infusion - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Intravenous infusion - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Intravenous infusion - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Intravenous infusion - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 56: Market opportunity by Route of Administration ($ billion)
o Exhibit 57: Data Table on Market opportunity by Route of Administration ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 Europe - Market size and forecast 2023-2028
o Exhibit 63: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 64: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.4 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 UK - Market size and forecast 2023-2028
o Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 China - Market size and forecast 2023-2028
o Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.11 France - Market size and forecast 2023-2028
o Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Aspen Pharmacare Holdings Ltd
o Exhibit 107: Aspen Pharmacare Holdings Ltd - Overview
o Exhibit 108: Aspen Pharmacare Holdings Ltd - Business segments
o Exhibit 109: Aspen Pharmacare Holdings Ltd - Key offerings
o Exhibit 110: Aspen Pharmacare Holdings Ltd - Segment focus
o 12.4 B.Braun SE
o Exhibit 111: B.Braun SE - Overview
o Exhibit 112: B.Braun SE - Business segments
o Exhibit 113: B.Braun SE - Key news
o Exhibit 114: B.Braun SE - Key offerings
o Exhibit 115: B.Braun SE - Segment focus
o 12.5 Baxter International Inc.
o Exhibit 116: Baxter International Inc. - Overview
o Exhibit 117: Baxter International Inc. - Business segments
o Exhibit 118: Baxter International Inc. - Key news
o Exhibit 119: Baxter International Inc. - Key offerings
o Exhibit 120: Baxter International Inc. - Segment focus
o 12.6 Eisai Co. Ltd.
o Exhibit 121: Eisai Co. Ltd. - Overview
o Exhibit 122: Eisai Co. Ltd. - Business segments
o Exhibit 123: Eisai Co. Ltd. - Key offerings
o Exhibit 124: Eisai Co. Ltd. - Segment focus
o 12.7 Fresenius SE and Co. KGaA
o Exhibit 125: Fresenius SE and Co. KGaA - Overview
o Exhibit 126: Fresenius SE and Co. KGaA - Business segments
o Exhibit 127: Fresenius SE and Co. KGaA - Key news
o Exhibit 128: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 129: Fresenius SE and Co. KGaA - Segment focus
o 12.8 Hikma Pharmaceuticals Plc
o Exhibit 130: Hikma Pharmaceuticals Plc - Overview
o Exhibit 131: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 132: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 133: Hikma Pharmaceuticals Plc - Segment focus
o 12.9 Laboratorios Farmaceuticos ROVI S A
o Exhibit 134: Laboratorios Farmaceuticos ROVI S A - Overview
o Exhibit 135: Laboratorios Farmaceuticos ROVI S A - Business segments
o Exhibit 136: Laboratorios Farmaceuticos ROVI S A - Key offerings
o Exhibit 137: Laboratorios Farmaceuticos ROVI S A - Segment focus
o 12.10 Nanjing Kingfriend Biochemical
o Exhibit 138: Nanjing Kingfriend Biochemical - Overview
o Exhibit 139: Nanjing Kingfriend Biochemical - Product / Service
o Exhibit 140: Nanjing Kingfriend Biochemical - Key offerings
o 12.11 Nichi Iko Pharmaceutical Co. Ltd.
o Exhibit 141: Nichi Iko Pharmaceutical Co. Ltd. - Overview
o Exhibit 142: Nichi Iko Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 143: Nichi Iko Pharmaceutical Co. Ltd. - Key offerings
o 12.12 Novartis AG
o Exhibit 144: Novartis AG - Overview
o Exhibit 145: Novartis AG - Business segments
o Exhibit 146: Novartis AG - Key offerings
o Exhibit 147: Novartis AG - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 148: Pfizer Inc. - Overview
o Exhibit 149: Pfizer Inc. - Product / Service
o Exhibit 150: Pfizer Inc. - Key news
o Exhibit 151: Pfizer Inc. - Key offerings
o 12.14 Sanofi SA
o Exhibit 152: Sanofi SA - Overview
o Exhibit 153: Sanofi SA - Business segments
o Exhibit 154: Sanofi SA - Key news
o Exhibit 155: Sanofi SA - Key offerings
o Exhibit 156: Sanofi SA - Segment focus
o 12.15 Shenzhen Techdow Pharmaceutical
o Exhibit 157: Shenzhen Techdow Pharmaceutical - Overview
o Exhibit 158: Shenzhen Techdow Pharmaceutical - Product / Service
o Exhibit 159: Shenzhen Techdow Pharmaceutical - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 165: Viatris Inc. - Overview
o Exhibit 166: Viatris Inc. - Business segments
o Exhibit 167: Viatris Inc. - Key news
o Exhibit 168: Viatris Inc. - Key offerings
o Exhibit 169: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 170: Inclusions checklist
o Exhibit 171: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 172: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 173: Research methodology
o Exhibit 174: Validation techniques employed for market sizing
o Exhibit 175: Information sources
o 13.5 List of abbreviations
o Exhibit 176: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global heparin market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Route Of Administration Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Low-molecular-weight heparin - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Low-molecular-weight heparin - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Low-molecular-weight heparin - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Low-molecular-weight heparin - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ billion)
Exhibits43: Data Table on Market opportunity by Product ($ billion)
Exhibits44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits45: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Route of Administration
Exhibits47: Data Table on Comparison by Route of Administration
Exhibits48: Chart on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Subcutaneous injection - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Subcutaneous injection - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Intravenous infusion - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Intravenous infusion - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Intravenous infusion - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Intravenous infusion - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Route of Administration ($ billion)
Exhibits57: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Aspen Pharmacare Holdings Ltd - Overview
Exhibits108: Aspen Pharmacare Holdings Ltd - Business segments
Exhibits109: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibits110: Aspen Pharmacare Holdings Ltd - Segment focus
Exhibits111: B.Braun SE - Overview
Exhibits112: B.Braun SE - Business segments
Exhibits113: B.Braun SE - Key news
Exhibits114: B.Braun SE - Key offerings
Exhibits115: B.Braun SE - Segment focus
Exhibits116: Baxter International Inc. - Overview
Exhibits117: Baxter International Inc. - Business segments
Exhibits118: Baxter International Inc. - Key news
Exhibits119: Baxter International Inc. - Key offerings
Exhibits120: Baxter International Inc. - Segment focus
Exhibits121: Eisai Co. Ltd. - Overview
Exhibits122: Eisai Co. Ltd. - Business segments
Exhibits123: Eisai Co. Ltd. - Key offerings
Exhibits124: Eisai Co. Ltd. - Segment focus
Exhibits125: Fresenius SE and Co. KGaA - Overview
Exhibits126: Fresenius SE and Co. KGaA - Business segments
Exhibits127: Fresenius SE and Co. KGaA - Key news
Exhibits128: Fresenius SE and Co. KGaA - Key offerings
Exhibits129: Fresenius SE and Co. KGaA - Segment focus
Exhibits130: Hikma Pharmaceuticals Plc - Overview
Exhibits131: Hikma Pharmaceuticals Plc - Business segments
Exhibits132: Hikma Pharmaceuticals Plc - Key offerings
Exhibits133: Hikma Pharmaceuticals Plc - Segment focus
Exhibits134: Laboratorios Farmaceuticos ROVI S A - Overview
Exhibits135: Laboratorios Farmaceuticos ROVI S A - Business segments
Exhibits136: Laboratorios Farmaceuticos ROVI S A - Key offerings
Exhibits137: Laboratorios Farmaceuticos ROVI S A - Segment focus
Exhibits138: Nanjing Kingfriend Biochemical - Overview
Exhibits139: Nanjing Kingfriend Biochemical - Product / Service
Exhibits140: Nanjing Kingfriend Biochemical - Key offerings
Exhibits141: Nichi Iko Pharmaceutical Co. Ltd. - Overview
Exhibits142: Nichi Iko Pharmaceutical Co. Ltd. - Product / Service
Exhibits143: Nichi Iko Pharmaceutical Co. Ltd. - Key offerings
Exhibits144: Novartis AG - Overview
Exhibits145: Novartis AG - Business segments
Exhibits146: Novartis AG - Key offerings
Exhibits147: Novartis AG - Segment focus
Exhibits148: Pfizer Inc. - Overview
Exhibits149: Pfizer Inc. - Product / Service
Exhibits150: Pfizer Inc. - Key news
Exhibits151: Pfizer Inc. - Key offerings
Exhibits152: Sanofi SA - Overview
Exhibits153: Sanofi SA - Business segments
Exhibits154: Sanofi SA - Key news
Exhibits155: Sanofi SA - Key offerings
Exhibits156: Sanofi SA - Segment focus
Exhibits157: Shenzhen Techdow Pharmaceutical - Overview
Exhibits158: Shenzhen Techdow Pharmaceutical - Product / Service
Exhibits159: Shenzhen Techdow Pharmaceutical - Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits165: Viatris Inc. - Overview
Exhibits166: Viatris Inc. - Business segments
Exhibits167: Viatris Inc. - Key news
Exhibits168: Viatris Inc. - Key offerings
Exhibits169: Viatris Inc. - Segment focus
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations